Barrick Gold Corporation (NYSE:ABX) hit a new 52-week low Thursday as it is currently trading at $16.93, below its previous 52-week low of $17.51 with eight million shares traded as of 10:01 a.m. ET. Average volume has been 19.6 million shares over the past 30 days.
Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model. NEW YORK ( TheStreet) -- Barrick Gold Corporation (NYSE: ABX) hit a new 52-week low Thursday as it is currently trading at $16.93, below its previous 52-week low of $17.51 with eight million shares traded as of 10:01 a.m. ET. Average volume has been 19.6 million shares over the past 30 days. Barrick has a market cap of $18.92 billion and is part of the basic materials sector and metals & mining industry. Shares are down 48.6% year to date as of the close of trading on Wednesday. Barrick Gold Corporation engages in the production and sale of gold and copper. It is also involved in exploration and mine development activities.
EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
TheStreet Ratings rates Barrick as a hold. The company's strengths can be seen in multiple areas, such as its expanding profit margins and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share, disappointing return on equity and weak operating cash flow. You can view the full Barrick Ratings Report. See all 52-week low stocks or get investment ideas from our investment research center. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more..